These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 14730505)

  • 1. Vitamin D receptor and analogs.
    Dusso AS; Thadhani R; Slatopolsky E
    Semin Nephrol; 2004 Jan; 24(1):10-6. PubMed ID: 14730505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV; Yang J; Fernandez E; Dusso A
    Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
    Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV; Yang J; Fernandez E; Dusso A
    Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
    Arcidiacono MV; Sato T; Alvarez-Hernandez D; Yang J; Tokumoto M; Gonzalez-Suarez I; Lu Y; Tominaga Y; Cannata-Andia J; Slatopolsky E; Dusso AS
    J Am Soc Nephrol; 2008 Feb; 19(2):310-20. PubMed ID: 18216322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor ligand therapy in chronic kidney disease.
    Gonzalez E
    Clin Nephrol; 2008 Oct; 70(4):271-83. PubMed ID: 18826852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
    Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
    J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and the parathyroid.
    Beckerman P; Silver J
    Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure].
    Dusilová Sulková S
    Vnitr Lek; 2012 Nov; 58(11):839-49. PubMed ID: 23256830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S; Zhang W; Mao J; Wang M; Ni L; Zhang M; Zhang Q; Chen J
    J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P; Akerstrom G; Westin G
    Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E; Finch J; Ritter C; Takahashi F
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D analogues for the management of secondary hyperparathyroidism.
    Martin KJ; González EA
    Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S34-40. PubMed ID: 11689385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
    Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Kunimoto K; Okamoto M; Imazeki I; Muragaki Y; Akizawa T
    Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
    J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
    Naveh-Many T; Volovelsky O
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.